While the healthcare sector is fighting to reach the finish line of finding a cure for coronavirus and putting an end to the worldwide misery it causes, cannabis is proving relief to people dealing with this crisis. This has put the cannabis sector in the limelight again -- not only highlighting the medical benefits of marijuana, but also giving an idea about the potential of this sector.
The sudden surge in marijuana sales amid the pandemic helped cannabis companies' revenues to skyrocket. Among the Canadian pot stocks, in my opinion, Aphria (NASDAQ: APHA) is in the best position, while Curaleaf Holdings (OTC: CURLF) and Green Thumb Industries (OTC: GTBIF) are the top U.S. cannabis players now.
While not every cannabis company has benefited, let me tell you why these three could not just survive the crisis but expand and become top players once all is back to normal.